ZHANG, Bin,BRAUN, Stephan,FITZGERALD, Jonathan Basil,KALRA, Ashish,LEONARD, Shannon
申请号：
PH12019500892
公开号：
PH12019500892A1
申请日:
2019.04.24
申请国别(地区):
PH
年份:
2019
代理人:
摘要：
Combination therapy regimens including liposomal irinotecan, oxaliplatin and 5-fluorouracil are useful in the treatment of gastric cancer, including treatment of patients diagnosed with previously untreated gastric cancer. The combination therapy can include the administration of liposomal irinotecan, oxaliplatin, leucovorin and 5-fluorouracil once every two weeks.
